High Telomerase Reverse Transcriptase (hTERT) Messenger RNA Level Correlates with Tumor Recurrence in Patients with Favorable Histology Wilms’ Tumor

作者: Norman E. Breslow , Tracy Bergemann , Christopher B. Umbricht , Elizabeth J. Perlman , Saraswati Sukumar

DOI:

关键词:

摘要: Telomerase is a reverse transcriptase that maintains chromosome ends, compensating for the progressive loss of DNA occurs during replication. High telomerase enzyme activity an unfavorable prognostic feature several types cancers. We investigated whether level predicts outcome patients with pediatric renal malignancy Wilms’ tumor. In case-cohort study 78 favorable histology tumor, we compared tumor levels in and without eventual recurrence. Three measures were used: ( ) activity; b expression hTR, RNA component telomerase; c mRNA hTERT , gene encodes catalytic enzyme. Of evaluable samples, 81% had detectable activity, 97% transcript, 100% hTR. Weak correlations observed between hTR r = 0.34, P 0.02) 0.32, 0.04). variables assessed, only correlated outcome. The median tumors recurrence was higher than (1.42 versus 0.97 units, 0.023, Wilcoxon). Univariate analysis as continuous variable suggested each unit increase increased risk (RR) by factor 1.66 [95% confidence interval (CI), 1.2–2.3; 2 units RR 6.40 (95% CI, 1.49–27.67, 0.013). Multivariate predictor recurrence, adjusted stage age at diagnosis, revealed 1.48 0.9–2.6; 0.16). Measurement may, therefore, enable clinicians to identify population high adjust their therapy accordingly. A larger will be necessary determine independent indicator. Further biological investigation warranted discern link prognosis causative or correlative.

参考文章(49)
Kenneth R. Shroyer, L. Chesney Thompson, Takayuki Enomoto, Joan L. Eskens, A. Laurie Shroyer, James A. McGregor, Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix. American Journal of Clinical Pathology. ,vol. 109, pp. 153- 162 ,(1998) , 10.1093/AJCP/109.2.153
Mieczyslaw A. Piatyszek, Christer Mehle, Börje Ljungberg, Jerry W. Shay, Göran Roos, Telomerase activity in human renal cell carcinoma Oncogene. ,vol. 13, pp. 161- 166 ,(1996)
Wolfgang Hilbe, Wolfgang Eisterer, Oliver E. Bechter, Josef Thaler, Thomas Kühr, Georg Pall, Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Research. ,vol. 58, pp. 4918- 4922 ,(1998)
William H. Westra, Christopher B. Umbricht, Robert Udelsman, Saraswati Sukumar, Martha A. Zeiger, Motoyasu Saji, Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Research. ,vol. 57, pp. 2144- 2147 ,(1997)
Masahiro Takakura, Taro Kanaya, Masaaki Tanaka, Satoru Kyo, Masaki Inoue, Expression of Human Telomerase Subunits and Correlation with Telomerase Activity in Cervical Cancer Cancer Research. ,vol. 58, pp. 1558- 1561 ,(1998)
Seiji Kondo, Yoshtkazu Tanaka, Yasuko Kondo, Masahiro Hitomi, Gene H Barnett, Yukihito Ishizaka, Jinbo Liu, Talat Haqqi, Akiko Nishiyama, Bryant Villeponteau, John K Cowell, Barbara P Barna, Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation The FASEB Journal. ,vol. 12, pp. 801- 811 ,(1998) , 10.1096/FASEBJ.12.10.801
Mieczyslaw A. Piatyszek, Silvia Bacchetti, Carol W. Greider, Jerry W. Shay, Ariel A. Avilion, Jyothi Gupta, Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues Cancer Research. ,vol. 56, pp. 645- 650 ,(1996)
Dawei XU, Astrid Gruber, Curt Peterson, Pavel Pisa, Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia British Journal of Haematology. ,vol. 102, pp. 1367- 1375 ,(1998) , 10.1046/J.1365-2141.1998.00969.X
Mieczyslaw A. Piatyszek, Naokuni Tatsumoto, Takashi Kodama, Eiso Hiyama, Takashi Yokoyama, Yoshiaki Murakami, Jerry W. Shay, Yuji Imamura, Yuichiro Matsuura, Keiko Hiyama, Telomerase activity in gastric cancer. Cancer Research. ,vol. 55, pp. 3258- 3262 ,(1995)
D M Green, N E Breslow, J B Beckwith, J Z Finklestein, P Grundy, P R Thomas, T Kim, S Shochat, G Haase, M Ritchey, P Kelalis, G J D'Angio, Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group. Journal of Clinical Oncology. ,vol. 16, pp. 3744- 3751 ,(1998) , 10.1200/JCO.1998.16.12.3744